Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126099603 | 12609960 | 3 | F | 20160719 | 20160823 | 20160801 | 20160831 | EXP | DE-AMGEN-DEUSP2016097743 | AMGEN | 0.00 | M | Y | 0.00000 | 20160831 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126099603 | 12609960 | 1 | PS | pegfilgrastim | PEGFILGRASTIM | 1 | Subcutaneous | 6 MG, 1 IN 1 D FOR 1 DAY | U | 125031 | 6 | MG | UNKNOWN FORMULATION | QD | |||||
| 126099603 | 12609960 | 2 | SS | RITUXIMAB | RITUXIMAB | 1 | Intravenous (not otherwise specified) | 690 MG,1 IN 1 D FOR 1 DAY | 0 | 690 | MG | SOLUTION FOR INFUSION | QD | ||||||
| 126099603 | 12609960 | 3 | SS | DOXORUBICIN | DOXORUBICIN | 1 | Intravenous (not otherwise specified) | 1 IN 1 D | 0 | QD | |||||||||
| 126099603 | 12609960 | 4 | SS | VINCRISTINE | VINCRISTINE | 1 | Intravenous (not otherwise specified) | 1 MG,1 IN 1 D | 0 | 1 | MG | QD | |||||||
| 126099603 | 12609960 | 5 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Oral | 425 MG, UNK, FOR 5 DAYS (LAST DOSE ON 15/JUL/2016) | 0 | 425 | MG | ||||||||
| 126099603 | 12609960 | 6 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | 1380 MG, 1 IN 1 D | 0 | 1380 | MG | QD | |||||||
| 126099603 | 12609960 | 7 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 300 MG, (1 IN 1 D) | 19800 | MG | 0 | 300 | MG | QD | |||||
| 126099603 | 12609960 | 8 | C | AMPHOTERICIN B. | AMPHOTERICIN B | 1 | Oral | 10 MG, (1 IN 1 D) | 0 | 10 | MG | QD | |||||||
| 126099603 | 12609960 | 9 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Oral | 20 MG, (1 IN 1 D) | 0 | 20 | MG | QD | |||||||
| 126099603 | 12609960 | 10 | C | COLECALCIFEROL | CHOLECALCIFEROL | 1 | Oral | UNK | 0 | ||||||||||
| 126099603 | 12609960 | 11 | C | SULFAMETHOXAZOLE AND TRIMETHOPRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Oral | 1920 MG (960 MG, 2 IN 1 D) | 0 | 960 | MG | BID | |||||||
| 126099603 | 12609960 | 12 | C | MACROGOL 3350 W/POTASSIUM CHLORIDE | 2 | Oral | UNK | 0 | |||||||||||
| 126099603 | 12609960 | 13 | C | ACICLOVIR | ACYCLOVIR | 1 | Oral | 800 MG (400 MG, 2 IN 1 D) | 0 | 400 | MG | BID | |||||||
| 126099603 | 12609960 | 14 | C | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | Oral | 500 MG (250 MG, 2 IN 1 D) | 0 | 250 | MG | BID | |||||||
| 126099603 | 12609960 | 15 | C | FLUCONAZOLE. | FLUCONAZOLE | 1 | Oral | 400 MG (200 MG, 2 IN 1 D) | 0 | 200 | MG | BID | |||||||
| 126099603 | 12609960 | 16 | C | NEBIVOLOL. | NEBIVOLOL | 1 | Oral | 5 MG (2.5 MG, 2 IN 1 D) | 0 | 2.5 | MG | BID | |||||||
| 126099603 | 12609960 | 17 | C | TORASEMIDE | TORSEMIDE | 1 | Oral | 5 MG, 1 IN 1 D | 0 | 5 | MG | QD | |||||||
| 126099603 | 12609960 | 18 | C | KALIUMCHLORIDE | 2 | Oral | 1200 MG (600 MG, 2 IN 1 D) | 0 | 600 | MG | BID | ||||||||
| 126099603 | 12609960 | 19 | C | AZITHROMYCIN ANHYDROUS. | AZITHROMYCIN ANHYDROUS | 1 | Oral | 500 MG,1 IN 1 D | 16500 | MG | 0 | 500 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126099603 | 12609960 | 1 | B-cell lymphoma |
| 126099603 | 12609960 | 2 | B-cell lymphoma |
| 126099603 | 12609960 | 3 | B-cell lymphoma |
| 126099603 | 12609960 | 4 | B-cell lymphoma |
| 126099603 | 12609960 | 5 | B-cell lymphoma |
| 126099603 | 12609960 | 6 | B-cell lymphoma |
| 126099603 | 12609960 | 7 | Hyperuricaemia |
| 126099603 | 12609960 | 9 | Abdominal pain upper |
| 126099603 | 12609960 | 10 | Vitamin D deficiency |
| 126099603 | 12609960 | 12 | Constipation |
| 126099603 | 12609960 | 15 | Candida infection |
| 126099603 | 12609960 | 16 | Tachycardia |
| 126099603 | 12609960 | 17 | Oedema |
| 126099603 | 12609960 | 18 | Hypokalaemia |
| 126099603 | 12609960 | 19 | Pneumonia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126099603 | 12609960 | DE |
| 126099603 | 12609960 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126099603 | 12609960 | Asthenia | |
| 126099603 | 12609960 | Cardiac failure | |
| 126099603 | 12609960 | Oedema | |
| 126099603 | 12609960 | Pleural effusion | |
| 126099603 | 12609960 | Pneumonia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126099603 | 12609960 | 1 | 20160715 | 0 | ||
| 126099603 | 12609960 | 2 | 20160711 | 0 | ||
| 126099603 | 12609960 | 3 | 20160712 | 0 | ||
| 126099603 | 12609960 | 4 | 20160712 | 0 | ||
| 126099603 | 12609960 | 5 | 20160711 | 0 | ||
| 126099603 | 12609960 | 6 | 20160712 | 0 | ||
| 126099603 | 12609960 | 7 | 20160426 | 20160630 | 0 | |
| 126099603 | 12609960 | 8 | 20160426 | 0 | ||
| 126099603 | 12609960 | 9 | 20160426 | 0 | ||
| 126099603 | 12609960 | 10 | 20160426 | 0 | ||
| 126099603 | 12609960 | 11 | 20160525 | 0 | ||
| 126099603 | 12609960 | 12 | 20160426 | 0 | ||
| 126099603 | 12609960 | 13 | 20160525 | 0 | ||
| 126099603 | 12609960 | 14 | 20160503 | 0 | ||
| 126099603 | 12609960 | 15 | 20160701 | 0 | ||
| 126099603 | 12609960 | 16 | 20160630 | 0 | ||
| 126099603 | 12609960 | 17 | 20160630 | 0 | ||
| 126099603 | 12609960 | 18 | 20160630 | 0 | ||
| 126099603 | 12609960 | 19 | 20160607 | 20160709 | 0 |